Product Information
FT CHEST CONGEST 400 MG CAPLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0656 per EA under NDC 70677105401. Its NADAC has been published 158 times since Sep 27, 2023.
Strength
400 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677105401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
1/27/2023
Pharmacological Classes
Price Statistics
The NADAC for FT CHEST CONGEST 400 MG CAPLET has been published 158 times since Sep 27, 2023, and over the history we have for it it has declined 9.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0656 per EA |
|---|---|
| All-time high | $0.0744 (Nov 13, 2024) |
| All-time low | $0.0644 (Oct 18, 2023) |
| 52-week high | $0.0683 |
| 52-week low | $0.0653 |
| Median price | $0.0681 |
| Average price | $0.0683 |
| Largest weekly change | -11.2% (Oct 18, 2023) |
| Weeks tracked | 158 |
| Tracking since | Sep 27, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT CHEST CONGEST 400 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for FT CHEST CONGEST 400 MG CAPLET, manufactured by Strategic Sourcing Services LLC, is $0.0656 per EA (NDC 70677105401), effective Sep 30, 2026.
How has the price of FT CHEST CONGEST 400 MG CAPLET changed over time?
Over the history we have for it, the NADAC for FT CHEST CONGEST 400 MG CAPLET has declined 9.6%. It has been tracked across 158 weekly CMS publications since Sep 27, 2023.
What are the highest and lowest recorded NADAC prices for FT CHEST CONGEST 400 MG CAPLET?
Since Sep 27, 2023, the NADAC for FT CHEST CONGEST 400 MG CAPLET has ranged from a low of $0.0644 (Oct 18, 2023) to a high of $0.0744 (Nov 13, 2024), with a median of $0.0681 per EA.
Are there cheaper alternatives to FT CHEST CONGEST 400 MG CAPLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FT CHEST CONGEST 400 MG CAPLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FT CHEST CONGEST 400 MG CAPLET?
FT CHEST CONGEST 400 MG CAPLET (NDC 70677105401) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.